

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.91296989 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 5.75035334 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.46510870 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.46510870 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44269094 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.44269094 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44269094 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44269094 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44269094 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.44269094 |
| 11 | response to peptidoglycan (GO:0032494) | 5.20599883 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.18594322 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.18594322 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.86272602 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.73648588 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55930247 |
| 17 | retinal cone cell development (GO:0046549) | 4.48376680 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45518346 |
| 19 | detection of other organism (GO:0098543) | 4.41871414 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.35313075 |
| 21 | detection of bacterium (GO:0016045) | 4.28615300 |
| 22 | * GMP metabolic process (GO:0046037) | 4.28495369 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26170465 |
| 24 | photoreceptor cell development (GO:0042461) | 4.07088946 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.06751071 |
| 26 | leukocyte aggregation (GO:0070486) | 4.04126943 |
| 27 | regulation of translational termination (GO:0006449) | 3.96478953 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79955956 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.79732819 |
| 30 | respiratory burst (GO:0045730) | 3.67969477 |
| 31 | eye photoreceptor cell development (GO:0042462) | 3.65417586 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.65331660 |
| 33 | NADH metabolic process (GO:0006734) | 3.64739082 |
| 34 | photoreceptor cell maintenance (GO:0045494) | 3.63702600 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.62794223 |
| 36 | retinal rod cell development (GO:0046548) | 3.56480535 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 3.52357579 |
| 38 | response to host immune response (GO:0052572) | 3.50206752 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.50206752 |
| 40 | cellular extravasation (GO:0045123) | 3.50000431 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.45432598 |
| 42 | neutrophil activation (GO:0042119) | 3.45340047 |
| 43 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.43736757 |
| 44 | positive regulation of nuclease activity (GO:0032075) | 3.43074117 |
| 45 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39828011 |
| 46 | protein retention in ER lumen (GO:0006621) | 3.36438068 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.35527646 |
| 48 | DNA deamination (GO:0045006) | 3.34501301 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.33135986 |
| 50 | response to host (GO:0075136) | 3.31830757 |
| 51 | response to host defenses (GO:0052200) | 3.31830757 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.31830757 |
| 53 | formation of translation preinitiation complex (GO:0001731) | 3.29695391 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28249514 |
| 55 | protein insertion into membrane (GO:0051205) | 3.27553401 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27477496 |
| 57 | granulocyte activation (GO:0036230) | 3.27125994 |
| 58 | phototransduction (GO:0007602) | 3.24634967 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.24594758 |
| 60 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.23574548 |
| 61 | adaptation of signaling pathway (GO:0023058) | 3.21268562 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18786816 |
| 63 | positive regulation of histone deacetylation (GO:0031065) | 3.18734249 |
| 64 | pentose-phosphate shunt (GO:0006098) | 3.17592926 |
| 65 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.17168530 |
| 66 | regulation of nuclease activity (GO:0032069) | 3.14036483 |
| 67 | negative regulation of cell size (GO:0045792) | 3.13364246 |
| 68 | regulation of translational fidelity (GO:0006450) | 3.12739366 |
| 69 | phototransduction, visible light (GO:0007603) | 3.11129319 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10031202 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09840807 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09366142 |
| 73 | nucleobase biosynthetic process (GO:0046112) | 3.08506917 |
| 74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.07358173 |
| 75 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06510315 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04110155 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.03929509 |
| 78 | protein maturation by protein folding (GO:0022417) | 3.03797704 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03690244 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 3.03471548 |
| 81 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.02910363 |
| 82 | cellular response to light stimulus (GO:0071482) | 3.02430728 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99409156 |
| 84 | regulation of regulated secretory pathway (GO:1903305) | 2.99071600 |
| 85 | detection of light stimulus (GO:0009583) | 2.97177191 |
| 86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96197885 |
| 87 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.94704135 |
| 88 | macrophage activation (GO:0042116) | 2.93892123 |
| 89 | positive regulation of protein deacetylation (GO:0090312) | 2.93558710 |
| 90 | mannose metabolic process (GO:0006013) | 2.92548149 |
| 91 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.92023177 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 2.90425147 |
| 93 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.88556157 |
| 94 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.88485852 |
| 95 | detection of light stimulus involved in visual perception (GO:0050908) | 2.88485852 |
| 96 | DNA unwinding involved in DNA replication (GO:0006268) | 2.87558820 |
| 97 | protein localization to endosome (GO:0036010) | 2.86016775 |
| 98 | detection of visible light (GO:0009584) | 2.82959291 |
| 99 | glucose catabolic process (GO:0006007) | 2.82583821 |
| 100 | regulation of chromatin binding (GO:0035561) | 2.81346206 |
| 101 | neutrophil mediated immunity (GO:0002446) | 2.79221660 |
| 102 | regulation of superoxide anion generation (GO:0032928) | 2.78031718 |
| 103 | purine nucleobase biosynthetic process (GO:0009113) | 2.77143347 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76143967 |
| 105 | positive regulation of mast cell activation (GO:0033005) | 2.75749891 |
| 106 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73409822 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73409822 |
| 108 | germinal center formation (GO:0002467) | 2.72466709 |
| 109 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.72366294 |
| 110 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.71247542 |
| 111 | protein localization to kinetochore (GO:0034501) | 2.70974766 |
| 112 | negative regulation of innate immune response (GO:0045824) | 2.70334203 |
| 113 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.69525627 |
| 114 | dosage compensation (GO:0007549) | 2.69202404 |
| 115 | visual perception (GO:0007601) | 2.68545475 |
| 116 | ribosome assembly (GO:0042255) | 2.68457802 |
| 117 | pinocytosis (GO:0006907) | 2.67387885 |
| 118 | response to interleukin-15 (GO:0070672) | 2.66388751 |
| 119 | regulation of defense response to virus by virus (GO:0050690) | 2.65677830 |
| 120 | sensory perception of light stimulus (GO:0050953) | 2.64617173 |
| 121 | protein-chromophore linkage (GO:0018298) | 2.64297259 |
| 122 | maternal placenta development (GO:0001893) | 2.63635560 |
| 123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62549722 |
| 124 | mitochondrion transport along microtubule (GO:0047497) | 2.62416230 |
| 125 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.62416230 |
| 126 | regulation of guanylate cyclase activity (GO:0031282) | 2.62194969 |
| 127 | ribosome biogenesis (GO:0042254) | 2.61710875 |
| 128 | modulation by virus of host process (GO:0019054) | 2.61706617 |
| 129 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61241513 |
| 130 | cellular response to unfolded protein (GO:0034620) | 2.60961704 |
| 131 | negative regulation of interleukin-6 production (GO:0032715) | 2.60579864 |
| 132 | modulation by symbiont of host cellular process (GO:0044068) | 2.60011628 |
| 133 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.59510988 |
| 134 | regulation of translational elongation (GO:0006448) | 2.59105353 |
| 135 | regulation of T cell tolerance induction (GO:0002664) | 2.58817078 |
| 136 | peptidyl-arginine methylation (GO:0018216) | 2.58653373 |
| 137 | peptidyl-arginine N-methylation (GO:0035246) | 2.58653373 |
| 138 | microglial cell activation (GO:0001774) | 2.58074317 |
| 139 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.57719322 |
| 140 | mitotic nuclear envelope disassembly (GO:0007077) | 2.56742430 |
| 141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56498016 |
| 142 | positive thymic T cell selection (GO:0045059) | 2.56364670 |
| 143 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.55997898 |
| 144 | NADPH regeneration (GO:0006740) | 2.55342004 |
| 145 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55156288 |
| 146 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.54935079 |
| 147 | regulation of mast cell activation (GO:0033003) | 2.54745652 |
| 148 | response to laminar fluid shear stress (GO:0034616) | 2.54537460 |
| 149 | nuclear envelope disassembly (GO:0051081) | 2.54512221 |
| 150 | membrane disassembly (GO:0030397) | 2.54512221 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.53857660 |
| 152 | cellular response to type I interferon (GO:0071357) | 2.53857660 |
| 153 | folic acid metabolic process (GO:0046655) | 2.53741980 |
| 154 | leukocyte degranulation (GO:0043299) | 2.53419754 |
| 155 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.53079573 |
| 156 | negative regulation of histone methylation (GO:0031061) | 2.52445598 |
| 157 | response to type I interferon (GO:0034340) | 2.52267712 |
| 158 | cellular response to topologically incorrect protein (GO:0035967) | 2.52099080 |
| 159 | B cell receptor signaling pathway (GO:0050853) | 2.51226309 |
| 160 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50192362 |
| 161 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.50020535 |
| 162 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49875723 |
| 163 | negative regulation of RNA splicing (GO:0033119) | 2.49787191 |
| 164 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.49325838 |
| 165 | sensory perception of smell (GO:0007608) | 2.49128960 |
| 166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48744092 |
| 167 | white fat cell differentiation (GO:0050872) | 2.48363214 |
| 168 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.48354036 |
| 169 | positive regulation of mast cell degranulation (GO:0043306) | 2.48354036 |
| 170 | positive regulation of B cell differentiation (GO:0045579) | 2.48247244 |
| 171 | IMP biosynthetic process (GO:0006188) | 2.48007302 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 2.47545278 |
| 173 | retina development in camera-type eye (GO:0060041) | 2.47445958 |
| 174 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.46903298 |
| 175 | nucleosome disassembly (GO:0006337) | 2.46223002 |
| 176 | protein-DNA complex disassembly (GO:0032986) | 2.46223002 |
| 177 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.46175783 |
| 178 | positive regulation of regulated secretory pathway (GO:1903307) | 2.45866024 |
| 179 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45656272 |
| 180 | negative regulation of type 2 immune response (GO:0002829) | 2.44593437 |
| 181 | mitotic G1/S transition checkpoint (GO:0044819) | 2.43845771 |
| 182 | ER-nucleus signaling pathway (GO:0006984) | 2.43261094 |
| 183 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.42197782 |
| 184 | translesion synthesis (GO:0019985) | 2.41393706 |
| 185 | vesicle coating (GO:0006901) | 2.41265899 |
| 186 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39399901 |
| 187 | morphogenesis of an endothelium (GO:0003159) | 2.38536711 |
| 188 | endothelial tube morphogenesis (GO:0061154) | 2.38536711 |
| 189 | regulation of translation in response to stress (GO:0043555) | 2.37703479 |
| 190 | GDP-mannose metabolic process (GO:0019673) | 2.35863661 |
| 191 | nuclear envelope organization (GO:0006998) | 2.34067520 |
| 192 | negative regulation of mRNA metabolic process (GO:1903312) | 2.33015969 |
| 193 | cytokinetic process (GO:0032506) | 2.32915859 |
| 194 | histone arginine methylation (GO:0034969) | 2.32440943 |
| 195 | regulation of protein heterodimerization activity (GO:0043497) | 2.30179227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13107239 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.64721588 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47365734 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.61949843 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42911047 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34436740 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23583123 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.20213733 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19278654 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.15646061 |
| 11 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.12844568 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03561064 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.01736583 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.01726833 |
| 15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93821354 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.90369425 |
| 17 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.88398110 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88142406 |
| 19 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83971650 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82899891 |
| 21 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81967418 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81137257 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.81097096 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79305051 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79238183 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78789509 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78719375 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78656020 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77766360 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76750160 |
| 31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75635187 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73811571 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72130447 |
| 34 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69439439 |
| 35 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68534614 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68285733 |
| 37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67593635 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65351838 |
| 39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64691796 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64552790 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62044424 |
| 42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.60786273 |
| 43 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.56400910 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56322392 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55990258 |
| 46 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.54094929 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52352987 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.52101094 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51744069 |
| 50 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50921799 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49869554 |
| 52 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.49627082 |
| 53 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48182555 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47031039 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45848658 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45585061 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43835980 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43780875 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43440506 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43424809 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42953252 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.42267187 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40710924 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40467998 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39930510 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38041432 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37082652 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36441328 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.36322058 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.36160013 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35814231 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35364837 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.34602038 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.34213534 |
| 75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34131650 |
| 76 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32710984 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32598376 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31656622 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.31537472 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30984452 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30855535 |
| 82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30193250 |
| 83 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30143898 |
| 84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29328417 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28609553 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28073386 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27883053 |
| 88 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27249179 |
| 89 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26921329 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26560505 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24400195 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23602208 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22822023 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22349204 |
| 95 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21952913 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21326319 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21067632 |
| 98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20656851 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20605818 |
| 100 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20509765 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20014336 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.19524744 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19492493 |
| 104 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19210604 |
| 105 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17766888 |
| 106 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16985780 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16024160 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15974504 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15921234 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14806004 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13880558 |
| 112 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.13873865 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13867635 |
| 114 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13748506 |
| 115 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13221023 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.13131437 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13113904 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10880161 |
| 119 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10548677 |
| 120 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09760272 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09318306 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08225795 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07910196 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 1.06950914 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06885203 |
| 126 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06616939 |
| 127 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06528116 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06516129 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06263303 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06062804 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05254767 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04904725 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04751771 |
| 134 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04520235 |
| 135 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.04469597 |
| 136 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03859948 |
| 137 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02362549 |
| 138 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01601816 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01191445 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00977998 |
| 141 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00731762 |
| 142 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00312336 |
| 143 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99452357 |
| 144 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99426842 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99219487 |
| 146 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99008715 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98685756 |
| 148 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98455281 |
| 149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98126876 |
| 150 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97276089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.30261936 |
| 2 | MP0003436_decreased_susceptibility_to | 3.96989520 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 3.77860194 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 3.43184768 |
| 5 | MP0003724_increased_susceptibility_to | 3.31440606 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.26600259 |
| 7 | MP0005253_abnormal_eye_physiology | 2.94128745 |
| 8 | MP0005451_abnormal_body_composition | 2.92482366 |
| 9 | MP0008260_abnormal_autophagy | 2.83394600 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.72970056 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.71156097 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.69201520 |
| 13 | MP0002419_abnormal_innate_immunity | 2.67850733 |
| 14 | MP0005025_abnormal_response_to | 2.39253048 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.37117448 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.35467108 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.32478440 |
| 18 | MP0002653_abnormal_ependyma_morphology | 2.26142081 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.21031014 |
| 20 | MP0000685_abnormal_immune_system | 2.10621771 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 2.08386507 |
| 22 | MP0009785_altered_susceptibility_to | 2.05417604 |
| 23 | MP0008961_abnormal_basal_metabolism | 2.02085514 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.01174706 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 1.98520909 |
| 26 | MP0001790_abnormal_immune_system | 1.98419474 |
| 27 | MP0005387_immune_system_phenotype | 1.98419474 |
| 28 | * MP0001819_abnormal_immune_cell | 1.97269064 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.97160670 |
| 30 | MP0002723_abnormal_immune_serum | 1.96963617 |
| 31 | MP0001800_abnormal_humoral_immune | 1.96553059 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.95330989 |
| 33 | MP0006082_CNS_inflammation | 1.94629386 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.92068584 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.91645808 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.91266676 |
| 37 | MP0009278_abnormal_bone_marrow | 1.82978645 |
| 38 | MP0004947_skin_inflammation | 1.81754839 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.80703014 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.79497244 |
| 41 | MP0005671_abnormal_response_to | 1.78821483 |
| 42 | MP0004233_abnormal_muscle_weight | 1.69971431 |
| 43 | MP0001730_embryonic_growth_arrest | 1.69808998 |
| 44 | MP0002132_abnormal_respiratory_system | 1.66611656 |
| 45 | MP0010307_abnormal_tumor_latency | 1.64670247 |
| 46 | MP0002405_respiratory_system_inflammati | 1.63189011 |
| 47 | MP0003828_pulmonary_edema | 1.60443205 |
| 48 | MP0003077_abnormal_cell_cycle | 1.59883016 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.59303529 |
| 50 | MP0005670_abnormal_white_adipose | 1.53329743 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.52403222 |
| 52 | MP0005195_abnormal_posterior_eye | 1.52309050 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.51024762 |
| 54 | * MP0000716_abnormal_immune_system | 1.49114038 |
| 55 | MP0005391_vision/eye_phenotype | 1.49053212 |
| 56 | MP0004858_abnormal_nervous_system | 1.48261258 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.47885479 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.47876857 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.47199688 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.47199688 |
| 61 | MP0001984_abnormal_olfaction | 1.47146834 |
| 62 | MP0004130_abnormal_muscle_cell | 1.46165096 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.43733460 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.42705709 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.42583581 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.39929081 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.38748484 |
| 68 | MP0003075_altered_response_to | 1.38354455 |
| 69 | MP0004381_abnormal_hair_follicle | 1.36684629 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.36281820 |
| 71 | MP0005394_taste/olfaction_phenotype | 1.34205604 |
| 72 | MP0005499_abnormal_olfactory_system | 1.34205604 |
| 73 | MP0005375_adipose_tissue_phenotype | 1.34166783 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 1.34027134 |
| 75 | MP0001944_abnormal_pancreas_morphology | 1.32391227 |
| 76 | MP0004510_myositis | 1.31235760 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.30322376 |
| 78 | MP0000490_abnormal_crypts_of | 1.29942578 |
| 79 | MP0002970_abnormal_white_adipose | 1.28310835 |
| 80 | MP0002080_prenatal_lethality | 1.27506214 |
| 81 | MP0009840_abnormal_foam_cell | 1.26607895 |
| 82 | MP0001324_abnormal_eye_pigmentation | 1.23692856 |
| 83 | MP0008469_abnormal_protein_level | 1.21011132 |
| 84 | MP0003984_embryonic_growth_retardation | 1.20488538 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.20089109 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 1.18049635 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 1.18047459 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.17657657 |
| 89 | MP0003303_peritoneal_inflammation | 1.17627778 |
| 90 | MP0002088_abnormal_embryonic_growth/wei | 1.17273970 |
| 91 | MP0000343_altered_response_to | 1.16675392 |
| 92 | MP0002638_abnormal_pupillary_reflex | 1.16037671 |
| 93 | MP0008007_abnormal_cellular_replicative | 1.14241727 |
| 94 | MP0005666_abnormal_adipose_tissue | 1.14132403 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 1.14104908 |
| 96 | MP0005380_embryogenesis_phenotype | 1.14104908 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 1.12307432 |
| 98 | MP0003300_gastrointestinal_ulcer | 1.12219215 |
| 99 | MP0001697_abnormal_embryo_size | 1.10689234 |
| 100 | MP0001849_ear_inflammation | 1.10633961 |
| 101 | MP0000750_abnormal_muscle_regeneration | 1.09507603 |
| 102 | MP0000358_abnormal_cell_content/ | 1.08658554 |
| 103 | MP0000678_abnormal_parathyroid_gland | 1.08504023 |
| 104 | MP0001851_eye_inflammation | 1.07891677 |
| 105 | MP0001873_stomach_inflammation | 1.07650027 |
| 106 | MP0002693_abnormal_pancreas_physiology | 1.07427356 |
| 107 | MP0002229_neurodegeneration | 1.06366031 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 1.04041093 |
| 109 | * MP0009333_abnormal_splenocyte_physiolog | 1.03826545 |
| 110 | MP0002019_abnormal_tumor_incidence | 1.03663180 |
| 111 | MP0005390_skeleton_phenotype | 1.02315182 |
| 112 | MP0003448_altered_tumor_morphology | 1.01871152 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.99724810 |
| 114 | * MP0002398_abnormal_bone_marrow | 0.99026729 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.98805015 |
| 116 | MP0003283_abnormal_digestive_organ | 0.98730817 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.98073268 |
| 118 | MP0000313_abnormal_cell_death | 0.96885847 |
| 119 | MP0003091_abnormal_cell_migration | 0.96345767 |
| 120 | MP0002085_abnormal_embryonic_tissue | 0.96230738 |
| 121 | MP0002722_abnormal_immune_system | 0.94051199 |
| 122 | MP0001853_heart_inflammation | 0.93570421 |
| 123 | MP0003279_aneurysm | 0.93198365 |
| 124 | MP0002084_abnormal_developmental_patter | 0.92937903 |
| 125 | MP0008058_abnormal_DNA_repair | 0.91361167 |
| 126 | MP0005310_abnormal_salivary_gland | 0.91158545 |
| 127 | MP0009764_decreased_sensitivity_to | 0.90302570 |
| 128 | MP0002086_abnormal_extraembryonic_tissu | 0.89527867 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.86309836 |
| 130 | MP0000747_muscle_weakness | 0.86308529 |
| 131 | MP0002269_muscular_atrophy | 0.84973518 |
| 132 | MP0002796_impaired_skin_barrier | 0.83714731 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.83307042 |
| 134 | MP0003123_paternal_imprinting | 0.83162820 |
| 135 | MP0001958_emphysema | 0.82718829 |
| 136 | MP0005166_decreased_susceptibility_to | 0.81964421 |
| 137 | MP0000604_amyloidosis | 0.81436297 |
| 138 | MP0004883_abnormal_blood_vessel | 0.80404720 |
| 139 | MP0003866_abnormal_defecation | 0.80321763 |
| 140 | MP0002090_abnormal_vision | 0.79226707 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.78914581 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.76732219 |
| 143 | MP0008004_abnormal_stomach_pH | 0.76150709 |
| 144 | MP0000689_abnormal_spleen_morphology | 0.75905303 |
| 145 | MP0003329_amyloid_beta_deposits | 0.75899247 |
| 146 | MP0005621_abnormal_cell_physiology | 0.75773092 |
| 147 | MP0004197_abnormal_fetal_growth/weight/ | 0.75225283 |
| 148 | MP0005164_abnormal_response_to | 0.74115627 |
| 149 | MP0003795_abnormal_bone_structure | 0.73521476 |
| 150 | MP0005384_cellular_phenotype | 0.71484687 |
| 151 | MP0006036_abnormal_mitochondrial_physio | 0.70117868 |
| 152 | MP0005083_abnormal_biliary_tract | 0.69544031 |
| 153 | MP0001764_abnormal_homeostasis | 0.69071747 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.69017922 |
| 155 | MP0002277_abnormal_respiratory_mucosa | 0.68986483 |
| 156 | MP0004084_abnormal_cardiac_muscle | 0.68713975 |
| 157 | MP0000767_abnormal_smooth_muscle | 0.68432477 |
| 158 | MP0009931_abnormal_skin_appearance | 0.67991054 |
| 159 | MP0010234_abnormal_vibrissa_follicle | 0.67431392 |
| 160 | MP0005501_abnormal_skin_physiology | 0.67133282 |
| 161 | MP0002127_abnormal_cardiovascular_syste | 0.67026286 |
| 162 | MP0001663_abnormal_digestive_system | 0.66991309 |
| 163 | MP0008770_decreased_survivor_rate | 0.66762120 |
| 164 | MP0009672_abnormal_birth_weight | 0.66566132 |
| 165 | * MP0002429_abnormal_blood_cell | 0.65896770 |
| 166 | MP0009115_abnormal_fat_cell | 0.65628058 |
| 167 | MP0000858_altered_metastatic_potential | 0.64753389 |
| 168 | MP0002971_abnormal_brown_adipose | 0.63793101 |
| 169 | MP0003786_premature_aging | 0.62657888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.06293974 |
| 2 | * Bony spicule pigmentary retinopathy (HP:0007737) | 6.79511388 |
| 3 | * Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.48002637 |
| 4 | * Abnormal rod and cone electroretinograms (HP:0008323) | 5.89063472 |
| 5 | Pendular nystagmus (HP:0012043) | 5.78123471 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.46533286 |
| 7 | Central scotoma (HP:0000603) | 5.45294627 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.99388611 |
| 9 | Scotoma (HP:0000575) | 4.84850215 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.83074429 |
| 11 | Posterior subcapsular cataract (HP:0007787) | 4.81985890 |
| 12 | Pigmentary retinal degeneration (HP:0001146) | 4.66848506 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.59613808 |
| 14 | Abnormality of macular pigmentation (HP:0008002) | 4.26516486 |
| 15 | Chorioretinal atrophy (HP:0000533) | 4.07337087 |
| 16 | Myositis (HP:0100614) | 4.07091151 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 3.99516544 |
| 18 | * Type II diabetes mellitus (HP:0005978) | 3.95579536 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 3.78830096 |
| 20 | Obstructive lung disease (HP:0006536) | 3.66973205 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66973205 |
| 22 | Severe visual impairment (HP:0001141) | 3.66425245 |
| 23 | Orchitis (HP:0100796) | 3.62051068 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52285034 |
| 25 | Dyschromatopsia (HP:0007641) | 3.37248183 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27983180 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.23508614 |
| 28 | Cellulitis (HP:0100658) | 3.21527745 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.12655256 |
| 30 | Gingivitis (HP:0000230) | 3.07176597 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.95748463 |
| 32 | * Photophobia (HP:0000613) | 2.93430387 |
| 33 | Recurrent skin infections (HP:0001581) | 2.93349094 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.92993314 |
| 35 | Optic neuritis (HP:0100653) | 2.92993314 |
| 36 | Hyperacusis (HP:0010780) | 2.88957634 |
| 37 | Increased IgE level (HP:0003212) | 2.88409312 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.85585535 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84014650 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84014650 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84014650 |
| 42 | Meningitis (HP:0001287) | 2.78952732 |
| 43 | Urticaria (HP:0001025) | 2.76582462 |
| 44 | Stomatitis (HP:0010280) | 2.74708519 |
| 45 | Subcapsular cataract (HP:0000523) | 2.66402553 |
| 46 | * Constricted visual fields (HP:0001133) | 2.66068080 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.63573221 |
| 48 | Hypercortisolism (HP:0001578) | 2.56523848 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.52787784 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.51964177 |
| 51 | Hand muscle atrophy (HP:0009130) | 2.51403232 |
| 52 | Petechiae (HP:0000967) | 2.49608667 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.49529808 |
| 54 | Loss of speech (HP:0002371) | 2.49362939 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46405081 |
| 56 | Peritonitis (HP:0002586) | 2.45835703 |
| 57 | Amyloidosis (HP:0011034) | 2.45282182 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.45251402 |
| 59 | Increased corneal curvature (HP:0100692) | 2.44489212 |
| 60 | Keratoconus (HP:0000563) | 2.44489212 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.37486917 |
| 62 | Decreased central vision (HP:0007663) | 2.35659120 |
| 63 | Increased serum ferritin (HP:0003281) | 2.35624361 |
| 64 | Macular degeneration (HP:0000608) | 2.35201375 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.35147079 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.33026202 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29461356 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29461356 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.27120361 |
| 70 | Hypochromic anemia (HP:0001931) | 2.26886113 |
| 71 | Colitis (HP:0002583) | 2.24762438 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.24711655 |
| 73 | Ependymoma (HP:0002888) | 2.24309706 |
| 74 | Abnormality of the lower motor neuron (HP:0002366) | 2.22416470 |
| 75 | Recurrent viral infections (HP:0004429) | 2.21071174 |
| 76 | Encephalitis (HP:0002383) | 2.19979617 |
| 77 | Purpura (HP:0000979) | 2.19100041 |
| 78 | Chest pain (HP:0100749) | 2.18855257 |
| 79 | Hypertensive crisis (HP:0100735) | 2.18842367 |
| 80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16724245 |
| 81 | Vasculitis (HP:0002633) | 2.14735234 |
| 82 | Episodic fever (HP:0001954) | 2.14487901 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.14012909 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.10828161 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.08477804 |
| 86 | Visual hallucinations (HP:0002367) | 2.07833318 |
| 87 | Increased connective tissue (HP:0009025) | 2.07140039 |
| 88 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.04860199 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 2.03269214 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 2.03269214 |
| 91 | Insomnia (HP:0100785) | 2.03262054 |
| 92 | Hypertriglyceridemia (HP:0002155) | 2.03134115 |
| 93 | Polygenic inheritance (HP:0010982) | 2.01936756 |
| 94 | Pustule (HP:0200039) | 2.00938016 |
| 95 | Angiofibromas (HP:0010615) | 1.98626445 |
| 96 | Adenoma sebaceum (HP:0009720) | 1.98626445 |
| 97 | Slow saccadic eye movements (HP:0000514) | 1.98288854 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 1.98164832 |
| 99 | Dysautonomia (HP:0002459) | 1.96016131 |
| 100 | Upper limb amyotrophy (HP:0009129) | 1.95981670 |
| 101 | Distal upper limb amyotrophy (HP:0007149) | 1.95981670 |
| 102 | Astrocytoma (HP:0009592) | 1.94869549 |
| 103 | Abnormality of the astrocytes (HP:0100707) | 1.94869549 |
| 104 | Bowel diverticulosis (HP:0005222) | 1.94614747 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 1.93780072 |
| 106 | * Retinitis pigmentosa (HP:0000510) | 1.92853984 |
| 107 | Epistaxis (HP:0000421) | 1.91755317 |
| 108 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91198924 |
| 109 | Pathologic fracture (HP:0002756) | 1.91003974 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90967584 |
| 111 | Osteomyelitis (HP:0002754) | 1.90319505 |
| 112 | Difficulty climbing stairs (HP:0003551) | 1.89898988 |
| 113 | Thoracolumbar scoliosis (HP:0002944) | 1.89584486 |
| 114 | Polycythemia (HP:0001901) | 1.87775731 |
| 115 | Metaphyseal cupping (HP:0003021) | 1.87262877 |
| 116 | Arterial thrombosis (HP:0004420) | 1.85293650 |
| 117 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84368410 |
| 118 | Dilatation of the ascending aorta (HP:0005111) | 1.83006246 |
| 119 | Keratoconjunctivitis (HP:0001096) | 1.82325043 |
| 120 | Choroideremia (HP:0001139) | 1.81936775 |
| 121 | Thin bony cortex (HP:0002753) | 1.81458759 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80079944 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80079944 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80079944 |
| 125 | Glomerulopathy (HP:0100820) | 1.79975836 |
| 126 | Axonal loss (HP:0003447) | 1.79705651 |
| 127 | Sepsis (HP:0100806) | 1.79450020 |
| 128 | Anorexia (HP:0002039) | 1.79082673 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.78891286 |
| 130 | Thoracic kyphosis (HP:0002942) | 1.78388932 |
| 131 | Hemoptysis (HP:0002105) | 1.78057465 |
| 132 | Cone-rod dystrophy (HP:0000548) | 1.77592696 |
| 133 | Ankle contracture (HP:0006466) | 1.77234820 |
| 134 | Achilles tendon contracture (HP:0001771) | 1.76792427 |
| 135 | Abnormality of iron homeostasis (HP:0011031) | 1.76553561 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.76110830 |
| 137 | Skin ulcer (HP:0200042) | 1.76063144 |
| 138 | Hemorrhage of the eye (HP:0011885) | 1.76001706 |
| 139 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75736870 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.74731508 |
| 141 | Retinal atrophy (HP:0001105) | 1.74076647 |
| 142 | Granulocytopenia (HP:0001913) | 1.73904811 |
| 143 | Enlarged penis (HP:0000040) | 1.73640474 |
| 144 | Hypochromic microcytic anemia (HP:0004840) | 1.73496341 |
| 145 | Annular pancreas (HP:0001734) | 1.72915828 |
| 146 | Increased IgM level (HP:0003496) | 1.72340384 |
| 147 | Viral hepatitis (HP:0006562) | 1.71669983 |
| 148 | Diminished motivation (HP:0000745) | 1.71283945 |
| 149 | Abnormality of the thoracic spine (HP:0100711) | 1.70709278 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.70484505 |
| 151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70484505 |
| 152 | Gingival bleeding (HP:0000225) | 1.69771795 |
| 153 | Cerebral hypomyelination (HP:0006808) | 1.69753444 |
| 154 | Hypermelanotic macule (HP:0001034) | 1.69283350 |
| 155 | Verrucae (HP:0200043) | 1.68986081 |
| 156 | Papilloma (HP:0012740) | 1.68986081 |
| 157 | Progressive visual loss (HP:0000529) | 1.67791083 |
| 158 | Hypoglycemic coma (HP:0001325) | 1.66157453 |
| 159 | Entropion (HP:0000621) | 1.65921518 |
| 160 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.65490820 |
| 161 | Carpal bone hypoplasia (HP:0001498) | 1.63805367 |
| 162 | * Wide nasal bridge (HP:0000431) | 1.62498065 |
| 163 | Abnormality of the motor neurons (HP:0002450) | 1.61736445 |
| 164 | Abnormal neuron morphology (HP:0012757) | 1.61736445 |
| 165 | Elfin facies (HP:0004428) | 1.60178077 |
| 166 | Myoglobinuria (HP:0002913) | 1.59462143 |
| 167 | Apathy (HP:0000741) | 1.58355418 |
| 168 | Growth hormone excess (HP:0000845) | 1.58221543 |
| 169 | Fasciculations (HP:0002380) | 1.57040706 |
| 170 | Neoplasm of the adrenal cortex (HP:0100641) | 1.56616930 |
| 171 | Severe short stature (HP:0003510) | 1.56109105 |
| 172 | Renal duplication (HP:0000075) | 1.55646292 |
| 173 | Prominent nose (HP:0000448) | 1.54929633 |
| 174 | Fatigue (HP:0012378) | 1.54535173 |
| 175 | Microretrognathia (HP:0000308) | 1.54287569 |
| 176 | Basal cell carcinoma (HP:0002671) | 1.54283474 |
| 177 | Insulin resistance (HP:0000855) | 1.51590119 |
| 178 | Macroorchidism (HP:0000053) | 1.49363938 |
| 179 | Vitreoretinal degeneration (HP:0000655) | 1.48927803 |
| 180 | Deep palmar crease (HP:0006191) | 1.48832143 |
| 181 | Glioma (HP:0009733) | 1.48597740 |
| 182 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.48517071 |
| 183 | Athetosis (HP:0002305) | 1.46633242 |
| 184 | Amyotrophic lateral sclerosis (HP:0007354) | 1.46489923 |
| 185 | Nasal polyposis (HP:0100582) | 1.45508761 |
| 186 | Bundle branch block (HP:0011710) | 1.44714595 |
| 187 | Cutaneous melanoma (HP:0012056) | 1.44466257 |
| 188 | Decreased subcutaneous fat (HP:0001002) | 1.44445447 |
| 189 | Ventricular fibrillation (HP:0001663) | 1.44417265 |
| 190 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.43519596 |
| 191 | Pelvic girdle muscle weakness (HP:0003749) | 1.43267128 |
| 192 | Abnormality of pain sensation (HP:0010832) | 1.42693338 |
| 193 | Impaired pain sensation (HP:0007328) | 1.42693338 |
| 194 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.42360778 |
| 195 | Personality changes (HP:0000751) | 1.42069302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.12724171 |
| 2 | MAP3K10 | 4.04187159 |
| 3 | EEF2K | 4.01664620 |
| 4 | ERN1 | 3.30508569 |
| 5 | PKN2 | 3.24476098 |
| 6 | RIPK4 | 3.21588895 |
| 7 | NEK1 | 2.82148187 |
| 8 | PRPF4B | 2.79961607 |
| 9 | SCYL2 | 2.75377067 |
| 10 | SMG1 | 2.70266176 |
| 11 | IRAK4 | 2.65825170 |
| 12 | IRAK3 | 2.51311993 |
| 13 | NEK2 | 2.35633624 |
| 14 | BLK | 2.08693493 |
| 15 | FLT3 | 2.08608241 |
| 16 | MAPKAPK3 | 2.08156139 |
| 17 | TYK2 | 1.93409474 |
| 18 | GRK1 | 1.91548826 |
| 19 | MAP3K3 | 1.88356256 |
| 20 | BUB1 | 1.80662222 |
| 21 | PASK | 1.80084570 |
| 22 | CSK | 1.75618930 |
| 23 | EPHB1 | 1.74374942 |
| 24 | CDK12 | 1.66605758 |
| 25 | TAOK2 | 1.59387745 |
| 26 | TNK2 | 1.57098450 |
| 27 | PIM2 | 1.53239724 |
| 28 | FES | 1.47719006 |
| 29 | RPS6KB2 | 1.47573038 |
| 30 | HIPK2 | 1.47310652 |
| 31 | ZAP70 | 1.46716893 |
| 32 | MAP4K1 | 1.46154061 |
| 33 | SIK2 | 1.45925905 |
| 34 | BCKDK | 1.39241656 |
| 35 | TAOK1 | 1.38749753 |
| 36 | WEE1 | 1.35502638 |
| 37 | RIPK1 | 1.34070757 |
| 38 | TBK1 | 1.33588700 |
| 39 | IRAK2 | 1.32590505 |
| 40 | MAP3K13 | 1.31809885 |
| 41 | MAP3K1 | 1.28451892 |
| 42 | ALK | 1.27078880 |
| 43 | KDR | 1.19021081 |
| 44 | RPS6KA4 | 1.17148214 |
| 45 | SIK3 | 1.14997762 |
| 46 | TESK2 | 1.13980195 |
| 47 | HCK | 1.11193931 |
| 48 | BRSK1 | 1.09058896 |
| 49 | ICK | 1.08956799 |
| 50 | PDPK1 | 1.07795378 |
| 51 | LRRK2 | 1.05996506 |
| 52 | EIF2AK3 | 1.01768207 |
| 53 | FGR | 1.01454766 |
| 54 | CDK4 | 1.00733732 |
| 55 | MAP3K14 | 0.99958367 |
| 56 | CCNB1 | 0.99827190 |
| 57 | PDGFRA | 0.98180369 |
| 58 | BRSK2 | 0.96993871 |
| 59 | MTOR | 0.95145457 |
| 60 | TSSK6 | 0.93951648 |
| 61 | TTN | 0.93010077 |
| 62 | CAMKK2 | 0.92452320 |
| 63 | MAP3K6 | 0.91790023 |
| 64 | MAP3K11 | 0.90840827 |
| 65 | CAMKK1 | 0.90520830 |
| 66 | PRKD3 | 0.83916420 |
| 67 | LATS2 | 0.82142253 |
| 68 | NME2 | 0.81419569 |
| 69 | KSR2 | 0.77423479 |
| 70 | PDK1 | 0.76964052 |
| 71 | RPS6KL1 | 0.75409220 |
| 72 | RPS6KC1 | 0.75409220 |
| 73 | GRK6 | 0.75118431 |
| 74 | CDC42BPA | 0.74954353 |
| 75 | BRAF | 0.74644912 |
| 76 | MARK3 | 0.71199778 |
| 77 | MATK | 0.71168161 |
| 78 | MAP3K9 | 0.70822350 |
| 79 | CSF1R | 0.70147226 |
| 80 | JAK2 | 0.69039439 |
| 81 | PDK3 | 0.68991521 |
| 82 | PDK4 | 0.68991521 |
| 83 | CDC7 | 0.68809373 |
| 84 | ACVR1B | 0.67748623 |
| 85 | MARK2 | 0.67595879 |
| 86 | DYRK3 | 0.67044835 |
| 87 | TGFBR1 | 0.66502517 |
| 88 | PRKCH | 0.65893819 |
| 89 | FGFR4 | 0.64818693 |
| 90 | RET | 0.63847771 |
| 91 | LYN | 0.63831067 |
| 92 | RPS6KA2 | 0.63798453 |
| 93 | CDK7 | 0.63235653 |
| 94 | STK10 | 0.62540714 |
| 95 | SIK1 | 0.62419508 |
| 96 | IKBKE | 0.62317389 |
| 97 | AURKA | 0.61444233 |
| 98 | CAMK1D | 0.58965342 |
| 99 | ILK | 0.57927247 |
| 100 | MAP3K8 | 0.56931689 |
| 101 | PLK1 | 0.56622063 |
| 102 | BMX | 0.55683428 |
| 103 | RPS6KA6 | 0.55343625 |
| 104 | TTK | 0.54680140 |
| 105 | LCK | 0.54560872 |
| 106 | MAP2K3 | 0.54127665 |
| 107 | JAK3 | 0.53799734 |
| 108 | TESK1 | 0.53710178 |
| 109 | MINK1 | 0.52964457 |
| 110 | PAK6 | 0.52956515 |
| 111 | RAF1 | 0.52475145 |
| 112 | IRAK1 | 0.51448075 |
| 113 | BTK | 0.51058139 |
| 114 | PAK2 | 0.51009253 |
| 115 | DAPK1 | 0.50905075 |
| 116 | NTRK1 | 0.49787726 |
| 117 | PRKG2 | 0.49438260 |
| 118 | TGFBR2 | 0.47961083 |
| 119 | ARAF | 0.47103821 |
| 120 | JAK1 | 0.46605137 |
| 121 | STK38 | 0.46377213 |
| 122 | CDK2 | 0.45996063 |
| 123 | CHEK1 | 0.45585535 |
| 124 | IKBKB | 0.44395913 |
| 125 | PINK1 | 0.44000149 |
| 126 | ITK | 0.43952500 |
| 127 | DYRK1B | 0.43727746 |
| 128 | PAK1 | 0.42710667 |
| 129 | MAPK12 | 0.42680502 |
| 130 | MAPK9 | 0.42666127 |
| 131 | ATR | 0.42326773 |
| 132 | PIM1 | 0.42099000 |
| 133 | PRKCI | 0.42054803 |
| 134 | EPHA2 | 0.41791786 |
| 135 | YES1 | 0.41761746 |
| 136 | SYK | 0.40881919 |
| 137 | AKT3 | 0.38535720 |
| 138 | MOS | 0.37943682 |
| 139 | ABL2 | 0.36580470 |
| 140 | PAK4 | 0.36357157 |
| 141 | CHEK2 | 0.36351574 |
| 142 | MAP2K2 | 0.36309072 |
| 143 | MAPK11 | 0.36162184 |
| 144 | PTK6 | 0.35706592 |
| 145 | AKT2 | 0.35650242 |
| 146 | PRKAA1 | 0.35121283 |
| 147 | RPS6KA1 | 0.33941836 |
| 148 | MAPKAPK2 | 0.33823283 |
| 149 | PRKD2 | 0.30874513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.78165259 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68517841 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.52514186 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40443432 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.39945322 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.38982708 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.95773402 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93901700 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 1.93564961 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.82818999 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68187804 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.66770302 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62801637 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.61781631 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60896055 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 1.56620387 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49554932 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.49520919 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47400550 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46710357 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44904038 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.39682342 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39546739 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.38370592 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.34006802 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31792586 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29800446 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.29592612 |
| 29 | Cell cycle_Homo sapiens_hsa04110 | 1.28866786 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.28235371 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27868584 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27242124 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26029416 |
| 34 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25615633 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24858008 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24373279 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.23947257 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23741639 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22926083 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21508180 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.19926652 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18834734 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18230967 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17575741 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12573491 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12467394 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11941466 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10067867 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.09782079 |
| 50 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.09568569 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.09376201 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07559175 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06130989 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03274963 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03140250 |
| 56 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02930999 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02775368 |
| 58 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01230948 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99948782 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95780485 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95192995 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93845473 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.93686699 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93337780 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92868715 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92081781 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89362834 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87474893 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.86860247 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.86840564 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.86492503 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86110560 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85936358 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84156652 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84124701 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84002701 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82996534 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81200800 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80692104 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80487670 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79947230 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79911407 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79671690 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.79498203 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79461013 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79065712 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77861675 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.77331600 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77190660 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77126862 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75213379 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75161218 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.74809678 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74737986 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74340707 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74077673 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73432191 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73146869 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.72215093 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71509091 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71163448 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70187871 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69950795 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69092136 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69050492 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69031352 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67653127 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67626175 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65883410 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64227720 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64035093 |
| 112 | * Purine metabolism_Homo sapiens_hsa00230 | 0.63948624 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63669638 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63663514 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63623513 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63482374 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.63048553 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63022869 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62836087 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62441970 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60463526 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60316802 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60225662 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.58934458 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58417090 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58331281 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58289089 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.57880425 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54934930 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54834869 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.54161972 |
| 132 | Ribosome_Homo sapiens_hsa03010 | 0.54076526 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.54045915 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52646463 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52451721 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.52435041 |
| 137 | Lysosome_Homo sapiens_hsa04142 | 0.51536116 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50683136 |
| 139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50658455 |
| 140 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50001447 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49418136 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49228579 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47868463 |
| 144 | RNA degradation_Homo sapiens_hsa03018 | 0.46965668 |
| 145 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45919243 |
| 146 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45903234 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44732593 |
| 148 | Shigellosis_Homo sapiens_hsa05131 | 0.43677237 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43281484 |
| 150 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43277404 |
| 151 | Hepatitis B_Homo sapiens_hsa05161 | 0.42944490 |

